The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

NCT03236636 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced HBV-Related Hepatocellular Carcinoma (HCC)

Interventions

DRUG: Icaritin
DRUG: HUACHANSU PIAN

Sponsor

Beijing Shenogen Biomedical Co., Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]